Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
Yue Zhong, Yuting Lu, Ying Sun, et al.
Expert Opinion on Drug Discovery (2017) Vol. 13, Iss. 1, pp. 75-87
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Extracellular Matrix Alterations in Metastatic Processes
Mayra Paolillo, Sergio Schinelli
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4947-4947
Open Access | Times Cited: 314
A Systematic Review of miR-29 in Cancer
Jason J. Kwon, Tricia D. Factora, Shatovisha Dey, et al.
Molecular Therapy — Oncolytics (2018) Vol. 12, pp. 173-194
Open Access | Times Cited: 204
Inhibition of MMPs and ADAM/ADAMTS
Charles J. Malemud
Biochemical Pharmacology (2019) Vol. 165, pp. 33-40
Open Access | Times Cited: 149
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
Shriefa Almutairi, Hanin Moh’d Kalloush, Nour A. Manoon, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5567-5567
Open Access | Times Cited: 44
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
Kevin Dzobo, Dimakatso Alice Senthebane, Chelene Ganz, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 101
Updating the role of matrix metalloproteinases in mineralized tissue and related diseases
Cíntia Kazuko Tokuhara, Mariana R. Santesso, Gabriela Silva Neubern de Oliveira, et al.
Journal of Applied Oral Science (2019) Vol. 27
Open Access | Times Cited: 78
The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
José Marı́a Gutiérrez, Laura-Oana Albulescu, Rachel H. Clare, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 451-451
Open Access | Times Cited: 64
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis
Shun Li, D. Mark Pritchard, Lu‐Gang Yu
Cancers (2022) Vol. 14, Iss. 13, pp. 3263-3263
Open Access | Times Cited: 44
Design and Structural Evolution of Matrix Metalloproteinase Inhibitors
Thomas Fischer, Nicole Senn, Rainer Riedl
Chemistry - A European Journal (2019) Vol. 25, Iss. 34, pp. 7960-7980
Closed Access | Times Cited: 63
Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting
Nabil Mohie Abdel‐Hamid, Shimaa A. Abass
Molecular Biology Reports (2021) Vol. 48, Iss. 9, pp. 6525-6538
Closed Access | Times Cited: 49
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Anna Fontana, Ilaria Cursaro, Gabriele Carullo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10014-10014
Open Access | Times Cited: 29
Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation
Thomas Fischer, Rainer Riedl
Molecules (2019) Vol. 24, Iss. 12, pp. 2265-2265
Open Access | Times Cited: 44
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma
Mircea Tampa, Simona Roxana Georgescu, Mădălina Irina Mitran, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 903-903
Open Access | Times Cited: 32
Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation
Fawzia Faleh Albelwi, Mohamed Teleb, Marwa M. Abu‐Serie, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10324-10324
Open Access | Times Cited: 27
Selective Inhibitors of Medium-Size S1′ Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery
Sandip Kumar Baidya, Suvankar Banerjee, Nilanjan Adhikari, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10709-10754
Closed Access | Times Cited: 22
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1151-1167
Closed Access | Times Cited: 20
Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition
Yung‐Wei Lin, Yu‐Ching Wen, Chi‐Hao Hsiao, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 352-352
Open Access | Times Cited: 11
The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review
Rui‐Ting Zhou, Xiaojie Luo, Xiang Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway
Yu Zheng, Chaojiang Chen, Zhuoyuan Lin, et al.
Biochemistry and Cell Biology (2019) Vol. 98, Iss. 3, pp. 396-404
Closed Access | Times Cited: 31
Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer
Aleksandra Kaczorowska, Natalia Miękus, Joanna Stefanowicz, et al.
Diagnostics (2020) Vol. 10, Iss. 8, pp. 547-547
Open Access | Times Cited: 31
Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
Emile Verhulst, Delphine Garnier, Ingrid De Meester, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 624-624
Open Access | Times Cited: 16
Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review
Lara Alessandrini, Laura Astolfi, Antonio Daloiso, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10733-10733
Open Access | Times Cited: 10
Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis
Yusha Wang, Yuhao Wei, Jing Huang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Pathological and therapeutic aspects of matrix metalloproteinases: implications in childhood leukemia
Yi‐Hsuan Hsiao, Shih‐Chi Su, Chiao‐Wen Lin, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 4, pp. 829-837
Closed Access | Times Cited: 29
Recent insights into natural product inhibitors of matrix metalloproteinases
Geetha B. Kumar, Bipin G. Nair, J. Jefferson P. Perry, et al.
MedChemComm (2019) Vol. 10, Iss. 12, pp. 2024-2037
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top